This book is based on clinical application and pharmacology as the core content, the clinical effect of neurotransmitter is the main line to write. The book is divided into three parts: the first part is the basic theory, clinical effect on neurotransmitter; the second part is the theory, the performance of each psychotropic drugs, including commodity name, specifications and packaging, reference price (retail price in Nanjing area in 2005 June), indication, dosage and usage, adverse reactions, taboo card, pharmacokinetics and drug drug interactions, let the doctor to fully understand the various properties of drugs; third part is the clinical application of this drug, common mental disease treatment. The latest progress of book information is mainly based on nearly 3 years of Foreign Journal of psychiatry, and combined with the clinical data, a new informative, aims to help psychiatrists to further understand the interactions between different characteristics and drug of psychotropic drugs, the rational use of drugs and better. This book is mainly suitable for psychiatrists, psychological doctor, psychiatric nurses and medical college students, the mental patient's family also has certain reference value.
Yu Dongshan, psychiatric production Affiliated Hospital of Nanjing Medical University, deputy chief physician, master's tutor. Chinese Journal of psychiatry of Foreign Medical Sciences contributing editors, psychiatry, medical professional literature published nearly 100 papers.
The first chapter of mental diseases and treatment mechanism of first schizophrenia second depression third other mental disorders mental pharmacological basis of second chapter first quasi 5- serotonin can effect the second section noradrenergic effect third day quasi dopaminergic effect fourth day anti dopamine D receptor fifth anti 5- effect of serotonin 2A receptor effect sixth section of anti a receptor effect of seventh anti a receptor effect section eighth anticholinergic effects in section ninth, anti histamine H receptor effect tenth day quasi 7- GABAergic effect eleventh day quasi glutamic acid N- methyl -D- aspartate receptor effect in section twelfth, the voltage sensitive sodium channel voltage sensitive calcium channel a thirteenth section of chapter third antipsychotic drugs in the first festival concept second typical antipsychotics third atypical antipsychotic clozapine risperidone, olanzapine quetiapine Zillah West ketone in the fourth chapter of antidepressants section tricyclic antidepressants second selective 5- HT reuptake inhibitor Fu Xiting Pa Rossi Dean Seculinvshaminsi Pullan third 5- serotonin reuptake inhibitor trazodone fourth 5- serotonin enhancers to body recovery Lang fifth selective norepinephrine reuptake inhibitor Rui Posey Ting moclobemide seventh 5- serotonin and noradrenaline double recovery blocker Wen La guanfacine eighth noradrenergic and specific 5- serotoninergic antidepressant mirtazapine fifth chapter mood stabilizers of carbonic acid lithium sodium valproate in Kama Si Pinto chapter sixth anti anxiety drug section benzene two nitrogen class? Drug second 5- of serotonin lA receptor agonist buspirone third section of new non benzene two nitrogen? Sedative hypnotic drug, 必登 seventh chapter in the treatment of schizophrenia in Section 1 of schizophrenia in the acute treatment of second schizophrenia comorbid symptoms in third schizophrenic maintenance treatment for fourth day antipsychotic the removal of fifth day old medicine for the treatment of schizophrenia in Chapter eighth, the treatment of affective disorders section mania full treatment of bipolar depression throughout the second day treatment of third day major depression treatment fourth of female depression treatment in section fifth, the treatment of senile depression sixth somatic symptoms of depression treatment in section seventh effects of depression factors of prognosis of drug name index
Medical Science @ 2017